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The 10.1.2 MoAb reacts with a novel (X chain that associates 
with the PI integrin chain and is widely distributed among 
epithelial and endothelial cells of human adult and fetal tis-
sues. In the epidermis and in other squamous epithelia, (X1O.1.2 
chains are expressed exclusively in the basal cell layer. Here 
we describe the immunohistochemical localization of (X1O.I.2 
in human epidermis, in other squamous epithelia, as well as in 
cultured keratinocytes. (X1O.1.2 chain localization has also been 
investigated in a variety of non-neoplastic and neoplastic 
lesions of the skin, the uterine cervix, and the lung. We show 
that (X1O.1.2 chains retain their basal keratinocyte localization 
in hyperplastic skin diseases and in benign tumors of the 
epidermis and that they are strongly expressed in basal cell 
I ntegrins are surface receptors that mediate cell-to-cell and cell-to-extracellular matrix adhesion that is relevant for a number of physiologic and pathologic phenomena (re-viewed in [1-5]). Integrins are heterodimers consisting of non-covalently linked a and P chains. Thus far, at least 15 
a chains and eight P chains have been recognized in a variety of 
possible combinations and functions [6,7]. PI chains are linked to 
several a chains (a l to as and G'y) to form receptors that mediate 
predominantly cell-to-extracellular matrix adhesion [8]. Recently, 
we have described a novel a chain, termed a lO.1.2, that associates 
with PI chains and is distinct from PI-linked a chains described 
previously [9]. This new integrin mediates cell-to-cell interactions 
such as those between thymocytes and thymic epithelial cells (TEe) 
[9]. The i~muno?istoche.rnical distribution of a!0.1.2 cha.ins has 
been investigated 111 a vanety of normal human tissues US111g the 
10.1.2 monoclonal antibody (MoAb) [9,10]. A strong expression of 
a 0.1.2 chains occurs in endothelial cells, particularly those of high e~dothelial venules in lymphoid tissues, and in a variety of epithelial 
cells [10]. In the epidermis and in other squamous epithelia, only the 
cells of the basal layer are stained on their apical and lateral surfaces 
and, less intensely, at their basal aspect [10]. This observation has 
prompted the present analysis of the localization of a lO.1.2 chains in 
normal, dysplastic, and neoplastic squamous epithelia, as well as in 
cultured keratinocytes. The aim of the study was that of defining 
the expression of alO.1.2 PI integrin in the course of normal differen-
tiation and of neoplastic transformation, and in tumor invasion. 
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carcinomas. In contrast, (X1O.1.2 expression is decreased in ke-
ratinocytes that differentiate in vitro and is lost in epidermal 
dysplastic conditions, in the invading front of squamous cell 
carcinomas of the epidermis, in microinvasive cervical 
cancers, and in well-differentiated squamous lung tumors. 
These findings indicate that (X 10. 1.2 PI integrin is downregu-
lated during keratinocyte differentiation in vitro and in vivo. 
Moreover, lack of (X 10. 1.2 expression in basal cells of squamous 
epithelia is associated with early dysplastic changes and with 
the acquisition of invasive capacity. Key words: adhesion mole-
cules/skin cancer/tumor invasion/metastasis. ] Invest Dermatol 
102:247-252,1994 
MATERIALS AND METHODS 
Human Tissues Biopsies from several non-neoplastic and neoplastic skin 
conditions were performed in patients admitted to our Department of Der-
matology for diagnostic purposes. Adu1t normal human skin was excised 
from breast surgical specimens. Skin biopsies from human fetuses of 17 to 19 
weeks of gestational age were perfonned during fetoscopy for prenatal diag-
nosis of hereditary skin conditions. Infonned consent was obtained when 
appropriate. 
Samples of the portio vaginalis of the uterine cervix were obtained from 
six patients hysterectomized because of uterine prolapse, uterine leiomyoma, 
and cervical carcinoma (two cases for each condition). 
Tissue from 11 squamous lung cancer patients was available at the time of 
surgery. Diagnosis was confirmed by routine histology. In the same samples, 
normal respiratory epithelium as well as bronchial epithelium with features 
of metaplasia, atypia, or frank neoplastic transformation could also be ana-
lyzed. 
All specimens were embedded in OCT compound, snap frozen in freon 
22, cooled in liquid nitrogen, and stored at - 80 0 C until sectioning. 
Epidermal Cell Suspensions Normal human skin was transferred into 
sterile Petri dishes and incubated at 37 0 C for 1 h with Dispase II (Boehringer 
Mannheim, Germany). Epidermis was separated from dermis and transferred 
in trypsin -ethylene diaminetetraacetic acid 0.05/0.02 w/v (Gibco Ltd., 
Scotland), pipetted vigorously and filtered through sterile nylon gauze. Sin-
gle-cell suspensions were cytocentrifuged for immunohistochemical stain-
ing or processed for immuno-e1ectron microscopy (IEM) (see below). 
Keratinocyte Culture Human keratinocytes obtained from normal skin 
samples were cultured in serum-free, low-Ca++ (0.1 roM) MCDB153 me-
dium supplemented with epidermal growth factor, hydrocortisone, insulin, 
and bovine pituitary extract (Irvine Scientific, Irvine, CA) [11]. Low-Ca++ 
medium was converted into high-Ca++ medium (1.2 111M) by addition of 
200 roM CaCI2 • Cells on passage 2 or 3 were transferred into Lab-Tek 
chamber slides (Miles Laboratories, Elkhart, IN) and used for immunohisto-
chemical and immuno-scanrung electron microscopy (ISEM) studies. 
Monoclonal Antibodies 10.1.2 is a MoAb (IgG,) de.rived from the fu-
sion ofP3Ul mouse myeloma cells with spleen cells from a mouse immu-
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Figure 1. Two-color immunofluorescent staining of epidermal cell sus-
pension with. MoAb GoH3 (Q6 ) and 10.1.2 (QIO.1.2)' QIO.1.2 chains are evenly 
distributed along the plasma membrane of keratinocytes (red fluorescence), 
whereas labeling for Q 6 chains yields a polar staining pattern (green fluores-
cence). Co-localization of QIO.1.2 and Q 6 chains is revealed by yellow fluores-
cence. Bar, 20 j.lm. 
nized with cultured human TEC (9). MoAb GoH3 (Immunotech, Delta 
Biologicals, Rome, Italy) is a rat MoAb specific for Q 6 integrin chains 
[12,13). lntegrin Q6P, was detected using the 3El MoAb (Telios Pharma-
ceutical Inc., San Diego, CAl. PI chains were localized using MoAb 4B4 
(Coulter, Hialeah, FL). Finally, the 400-kD epitope of human laminin was 
identified using MoAb 1921 (Chemetron Products, Milano, Italy). 
Immunohistochemical Staining Cryostat sections, air-dried overnight 
and fixed with acetone for 10 min, were rinsed in 0.05 M Tris-buffered 
saline (TBS), pH 7.6, and incubated for 15 min with 10% heat-inactivated 
human AB serum and 10% rabbit serum in TBS. Specimens were subse-
quently incubated for 1 h at room temperature with the 10.1.2 MoAb 
(undiluted culture supernatant containing bovine serum albumin 1 % and Na 
azide 0.1 %). Sections were rinsed twice in TBS for 10 min and processed 
with the APAAP method (14). Secondary reagents were rabbit anti-mouse 
IgG affinity-purified antiserum and alkaline phosphatase-anti-alkaline 
phosphatase (APAAP) purchased from Dakopatts (Glostrup, Denmark). 
The reaction was revealed using New Fuchsin, naphthol AS-BI phosphate 
sodium salt, and 1 mM levamisole (all from Sigma Chemicals, St. Louis, 
MO). Samples were counterstained with Mayer's hematoxylin, and 
mounted in DPX. Some specimens were also processed using peroxidase-
anti-peroxidase or avidin-biotin complex techniques (10). 
Two-Color Immunofluorescence Cytocenrrifuge preparations of epi-
dermal cell suspensions, dried and fixed as described, were hydrated in Tris-
buffered saline (TBS) and incubated for 15 min with 10% heat-inactivated 
human AB serum and 10% goat serum in TBS and then for 1 h with the 
10.1.2 MoAb. After being rinsed in TBS, specimens were incubated for 1 h 
with tetramethyl rhodamine isothiocyanate (TRITC)-conjugated F (ab'), 
fragments of goat IgG antibodies to mouse IgG (Technogenetics, Milan, 
Italy), and again for 30 min with the 10.1.2 MoAb to avoid non-specific 
binding of the TRITC goat anti-mouse reagent. After a 10-min rinse with 
TBS, specimens were incubated for 1 h with the GoH3 rat MoAb followed 
by mouse-adsorbed fluorescein isothiocyanate-conjugated goat IgG to rat 
IgG (Cappel, West Chester, USA) diluted 1 : 50 in TBS. Specimens were 
washed in TBS, mounted in glycerol- phosphate-buffered saline, and exam-
ined with a Zeiss fluorescence microscope. 
Transmission IEM Epidermal single-cell suspensions and enzyme-
isolated epidermal sheets, either unfixed or fixed with 0.2% glutaraldehyde 
in Hepes buffer, were incubated for 15 min with PBS containing 10% heat-
inactivated human AB serum and 10% goat serum. Specimens were subse-
quently incubated with the 10.1.2 MoAb for 1 h at 4°C, followed by goat 
anti-mouse Ig antibodies labeled with 5-nm colloidal gold particles (GAM-
G5, Janssen Pharmaceutica, Beerse, Belgium). Samples were rinsed in PBS 
followed by 0.1 M cacodylate buffer, and fixed with 2% glutaraldehyde in 
cacodylate buffer. They were post-fixed with 1 % OsO. in cacodylate buffer, 
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Figure 2. !EM localization of QIO.1.2 chains in basal keratinocytes by lln-
munogold labelling. a) Gold particles are distributed along the lateral and 
apical cell surfaces. A few granules are also detected at the dermal pole, but 
never in association with hemidesmosomes (arrows) . b) Gold particles are 
preferentially associated with short villous protrusions of the plasma mem-
brane. Bars: a, 0.6 j.lm; b, 0.3 j.lm. 
dehydrated with a graded ethanol series, and embedded in EponAraldite. 
Ultrathin sections were analyzed with a Philips 400 electron microscope. 
ISEM of Cultured Keratinocytes Keratinocytes grown in Lab-Tek 
chamber slides were prefixed with 0.2% glutaraldehyde in 0.1 M PIPES 
buffer, pH 7.4, for 10 min at room temperature, rinsed for 20 min with 1 % 
glycine in PBS, and incubated for 20 min in PBS containing 1 % bovine 
serum albumin, 0.1 % Na azide and 10% heat-inactivated human AB serum. 
Cells were subsequently reacted for 30 min with the 10.1.2 MoAb and after 
rinsing in PBS were incubated for 1 h with goat anti-mouse Ig coupled with 
40-nm colloidal gold particles (Janssen). Cells were post-fixed for 30 min 
with 2% glutaraldehyde in PBS, rinsed in distilled water, dehydrated in 
graded alcohols, and critical point dried. Samples were finally coated with a 
carbon film and examined with a Pl1ilips 505 SEM equipped with scintillator 
type back scattered-electron detectors. 
RESULTS 
Normal Adult and Fetal Epidermis The localization of the 
10.1.2 MoAb in human skin has been described previously [9,10]. 
Briefly, a strong expression of a 10.1.2 chains is found in the basal cell 
layer of the epidermis. The staining is peripheral and often more 
intense along the apical and lateral surfaces than on the deep surface 
of the basal cells. Suprabasal keratinocytes are not stained. In the 
epidermis from 17- to 19-week-old fetuses, a lO.!.2 chains are 10cal-
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Figure 3. Expression of a lO.1.2 chains in cultured keratinocytes. a) APAAP 
reaction showing heavier staining of smaller cells. b,c) ISEM analysis of 
cultured keratinocytes stained for a lO.1.2' Gold particles, shown to better 
advantage with the backscattered electron mode (c), are distributed predom-
inantly in cell-to-cell contact areas. Bars: a, 20 pm; b,c, see photographs. 
Figure 4. APAAP staining of skin basal cell carcinoma and squamous cell 
carcinoma. a) Tumor cell islands of basal cell carcinoma are uniformly 
stained by MoAb to a lO.1.2' b) Staining for a lO.1.2 chains is confined to the 
periphery of tumor areas and is sharply interrupted at the front of tumor cell 
invasion (see also inset). c) a6 chains are expressed in the deeper invading 
areas of the tumor that are not stained by the 10.1.2 MoAb. d) Staining with 
MoAb to laminin reveals a discontinuous reaction in the basement mem-
brane (arrows). Bars: a,d, 200 IJ.m; b,c, 500 pm. 
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Figure 5. Microinvasive cervical carcinoma stained with peroxidase-anti-
peroxidase for PI integrin chains (a) and with APAAP for lXlO.1.2 (b). All of 
the tumor cells are positive for PI integrin chains but negative for lX 10. 1.2 . The 
latter molecule persists in the basal cell layer of the epithelium, which is 
disarrayed in the area of neoplastic microinvasion. Bars: a,b, 50 }.lm. 
ized in the basal layer. Periderma and/or suprabasal cells are consist-
ently negative (data not shown). 
Epidermal Cell Suspensions Two-color immunofluorescence 
staining of epidermal cell suspensions with mouse MoAb 10.1.2 and 
rat MoAb GoH3 shows that most of the 0'6-positive cells (i.e., basal 
keratinocytes) are also labeled by the 10.1.2 MoAb. The 10.1.2 
MoAb decorates uniformly the entire cell membrane of basal kerati-
nocytes, whereas staining for GoH3 is detected only at the dermal 
pole (Fig 1). 
IEM Analysis of Epidermal Cells IEM experiments were per-
formed using fresh epidermal cell suspensions and epidermallami-
nae stained with the 10.1.2 MoAb. Reactive cells in epidermal cell 
suspensions show gold particles along the entire cell membrane, but 
never in association with junctional structures (Fig 2) . 
In isolated epidermal sheets, the immunogold labeling is local-
ized predominantly on the lateral and apical surfaces of basal kerati-
nocytes, but rare gold particles are also scattered on the dermal 
surface of these cells (data not shown). 
Cultured Keratinocytes The immunohistochemical staining of 
cultured keratinocytes reveals a surface localization of 0'10.1.2 chains, 
particularly where intercellular contacts occur. Smaller, least differ-
entiated, cells stain for 0'10.1.2 more heavily than larger cells (Fig 3a). 
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This staining pattern is confirmed by ISEM analyses showing that 
gold particles are detected on peripheral cell projections, particu-
larly in the cell-to-cell contact areas (Fig 3b,c). 
Hyperproliferative Conditions and Benign Tumors of the 
Epidermis The pattern of 0'10.1.2 chain distribution in psoriasis, 
common warts, condylomata acuminata, and oral hairy leukoplakia 
is comparable to that of normal epidermis (data not shown). Among 
benign epidermal tumors, seborrheic keratosis and clear-cell 
acanthoma were analyzed. Also in these lesions a reaction with the 
10.1.2 MoAb is found in basal keratinocytes only (data not shown). 
Basal Cell Carcinoma In all of the basal cell carcinomas, a 
strong homogeneous labeling of neoplastic cell nodules with an 
intercellular staining pattern is detected (Fig 4a). In the adjacent 
normal epidermis, the 10.1.2 MoAb reacts exclusively with the 
basal cell layer. 
Actinic Keratosis, Keratoacanthoma, and Squamous Cell 
Carcinoma The epidermal basal layer in actinic keratosis and 
keratoacanthoma skin biopsies reacts quite intensely with the 10.1.2 
MoAb. However, dysplastic cells in actinic keratosis and kerato-
acanthoma lesions that extend in depth from the basis of the crater 
into the dermis, are consistently negative (data not shown). 
Several squamous cell carcinomas were stained with antibodies to 
0'10.1.2 chains, to 0'6P4 integrin and to laminin. The 10.1.2 MoAb 
reacts with the majority of the cells in the peripheral layer of the 
tumor cell cords and nodules. Staining is absent in malignant epi-
dermal cells located in the center and, notably, in the front of the 
tumor where aggregates of neoplastic cells invade the underlying 
dermal tissue (Fig 4b). In sharp contrast, MoAb to 0'6P4 integrin that 
in normal epidermis stains exclusively the dermal aspect of basal 
keratinocytes, reacts with the majority of squamous cell carcinoma 
cells (Fig 4c) and often exhibits a pattern reciprocal to that yielded 
by MoAb 10.1.2 (Fig 4b,c). Using anti-Iaminin MoAb we could 
show discontinuities in the staining of the basal lamina in the deep 
portions of the tumor cords, where tumor cells are negative for 
0'10.1.2 chains (Fig 4d). 
Portio Vaginalis of the Uterine Cervix and Cervical 
Cancer The squamous epithelium on the outer surface of the 
portio vaginalis was stained with the 10.1.2 MoAb in a variety of 
conditions. Epithelium overlying normal and inflammatory muco-
sal areas is stained by the 10.1.2 MoAb in the basal layer exclusively 
(data not shown) . We also analyzed the localization of 10.1. 2 MoAb 
in two squamous cervical cancers, one of which was diagnosed as 
microinvasive carcinoma, whereas the other was deeply spread into 
the lamina propria and the muscle layer. As shown in Fig 5b, cells of 
the microinvasive carcinoma do not stain with the 10.1.2 MoAb 
which reacts with the disarrayed basal layer where malignant cel1~ 
invade the lamina propria. Interestingly, these tumor cells negative 
for 0'10.1.2 chains stain for PI chains (Fig Sa). In the case of invasive 
cervical cancer, MoAb 10.1.2 stains certain tumor cells but not 
others. Positive cells are usually found at the periphery of tumor cell 
clusters and are smaller than central cells, which do not express 
0'10.1.2 chains and display marked nuclear atypias (data not shown). 
Squamous Lung Cancer Normal bronchial epithelium in lung 
specimens from squamous cancer patients is stained in the basal layer 
by the 10.1.2 MoAb. Ciliated and goblet cells are not stained. In 
certain epithelial areas, a proliferation of basal cells, with or without 
overlying columnar cells, was noted . All of the basal cells in these 
areas express 0'10.1.2 chains (Fig 6a). In squamous metaplasia, only 
cells in the basal layer are stained (Fig 6b). 
Cell cords and nodules of squamous cancer display a variable 
degree of keratinization. Tumor aggregates with advanced cell dif-
ferentiation and central keratinization are consistently negative. In 
well-differentiated tumor areas, only peripheral cells react with the 
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Figure 6. Immunohistochemical localization of a lO. L2 chains in lung tissue. a) Section of an interlobular bronchus with normal and metaplastic epithelial 
lining (arrow). In both areas, basal epithelial cell~ arc stained: ~) An area of squmlOus meta.plasia in the bronchial epi~helium. Discontinous stainin~ ~f the basal 
layer is of note (arrow) . c) Squamous lung carcmoma. PosItive cells are seen 111 the penphery of the neoplastiC tissue. Areas With heavy keratlruzatlOn are 
negative. d) Cells in poorly differentiated lung carcinoma (large cell cancer) stain strongly for a l? 1:2 chams. The normal bronchial epithelium (lOp right) shows 
a positive reaction in the basal cells. a,c,d) peroxidase-anti-peroxidase staining. b) APAAP stammg. Bars: a,b,c, 100 j.J.m; d, 50 j.J.m. 
10.1.2 MoAb (Fig 6c), whereas in poorly differentiated squamous 
lung cancer all of the tumor cells stain strongly (Fig 6d). 
DISCUSSION 
In human epidermis and in other squamous epithelia, molecules of 
the integrin family are expressed predominantly on cells of the basal 
layer where they mediate cell-to-cell and cell-to-extracellular ma-
trix adhesive interactions [15 -19]. On the surface of basal keratino-
cytes, a differential expression of integrins is detected on the deep 
cell surface opposed to the basement membranes as compared with 
the lateral and apical surfaces [19-21J (Fig 7). PI chains are ex-
pressed at high density on the apical and lateral cell surfaces, and at 
lower density on the basal surface where they localize between 
hemidesmosomes. In contrast, P4 chains are detected on hemides-
mosomes. a2 , a3 , and a 6 integrin chains, which associate with PI 
chains, are found at variable density on the entire surface of basal 
keratinocytes. a 6 chains that also associate with P4 chains are 
strongly expressed on the basal keratinocyte surface, both on hemi-
desmosomes and between them [21]. 
In this study we have analyzed the distribution of a novel integrin 
a chain, termed a lO. L 2 , which associates exclusively with PI chains 
and has been detected previously in the basal cell layer of the epider-
mis and of other squamous epithelia [9,10]. Immunofluorescence 
and ultrastructural analyses show that aW.1.2 chains are expressed on 
the surface of basal keratinocytes where they associate with PI 
chains evenly expressed on the lateral and apical surfaces, and in the 
inter-desmosomal areas of the basal cell membrane (Fig 7). 
Integrins are expressed in the early development of the human 
epidermis [17,22]. Some integrin chains, e.g., PI' maintain the same 
(peribasal) localization both prior to and following the onset of 
stratification. In contrast, other chains, e.g., P4 and a6 , display a 
uniform peribasallocalization in early epidermal development, but 
redistribute later, to concentrate exclusively or predominantly on 
the deep cell surface of basal keratinocytes. a lO.1.2 chains, at least in 
the developmental stages examined, show the same localization as 
in adult epidermis. Data from cultured keratinocytes indicate that 
a IO.!.2 chains are lost gradually during in vitro differentiation and 
that they are expressed at higher density in the cell-to-cell contact 
regions. 
Certain integrins are over-exl?ressed in hyperproliferative skin 
conditions such as psoriasis [23J . This is not the case for a lO. L2 
chains, which retain a normal distribution pattern in psoriasis as 
well as in virus-related skin lesions and in benign tumors of the 
epidermis. 
There is increasing evidence indicating that integrins as well as 
other adhesion molecules playa major role in tumor cell growth, 
spreading, and metastasis [24 - 29]. On one hand, over-expression of 
certain adhesive receptors may hold cells together in the primary 
tumor site or else direct their homing into preferential anatomical 
sites. On the other hand, down-regulation of adhesive receptors has 
been associated with the rapidly invasive course of tumors such as 
Burkitt's lymphoma and terminal multiple myeloma [30-33J. 
Thus, studies on the expression of adhesion molecules on tumor 
cells are of relevant diagnostic significance for the phenotypic defi-
nition of tumors and may contribute to the understanding of the 
pathogenesis and course of disease. 
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Figure 7. Schematic distribution of a and P integrin chains in the basola-
teral plasma membrane of basal keratinocytes (according to [21] and to our 
own observations). 
CXIO.1.2 chains are strongly expressed in all of the basal cell carci-
noma cells with a pattern s.imilar to that observed for other Pt-asso-
ciated CX chains (e.g., CX2 and cx3), and distinct from that of P4 chains, 
which are detected only in the periphery of basal cell carcinoma 
tumor islands [19,34,35]. In sharp contrast, lack of CX IO.1.2 expression 
has been observed in squamous cell carcinoma of the skin, of the 
uterine cervix, and of the lung. In skin squamous cell carcinoma, 
CXtO.1.2 chains are notably absent on cells at the tumor invading fr~nt 
where the basement membranes are undetectable or irregularly lll-
terrupted. On the contrary, cells in the same and in other areas of 
skin squamous cell carcinoma exhibit a strong expression of CX6P4 
integrin [34]. Absence of CX IO.1.2Pt and expression of CX6P4 were also 
the features of dysplastic cells in actinic keratosis and keratoacanth-
oma, suggesti!1g that CX tO.1.2 chains may be lost in the early steps of 
neoplastic transformation. CX IO.1.2 chains are also undetectable on 
cells of micro invasive squamous cancer of the cervix and in well-
differentiated squamous lung cancer, but are expressed on cells from 
poorly differentiated lung squamous cell carcinoma, in most neo-
plastic areas of the bronchial epithelium, and in certain cells (smaller 
and less atypic) of invasive cervical cancers. Interestingly, tumor 
cells that have lost CX tO.1.2 chains express Pt integrin chains, presum-
ably associated with other cx chains. 
Altogether, the above observations suggest that expression of 
CXIO.1.2 chains on tumor cells, and their absence thereof, may repre-
sent a useful phenotypic indicator of differentiation and invasivity 
of squamous epithelial cells undergoing neoplastic transformation. 
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